Hims and Ozempic: Semaglutide, Brand vs Molecule Explained

Last reviewed: May 12, 2026 Last updated: May 12, 2026

Written by: Jay Hastings , CEO of PlexusDx

Jay Hastings is the CEO of PlexusDx, a precision health company focused on genetic testing, blood biomarker insights, and personalized wellness recommendations. He has more than 20 years of experience across healthcare innovation, genomics, laboratory operations, healthcare investing, and strategic finance. His work has included scaling healthcare startups, leading CLIA lab integrations, and helping expand consumer access to precision health tools.

Medically reviewed by: Jayden Lee, PharmD, EMBA

Jayden Lee, PharmD, EMBA, is the PlexusDx Medical Science Liaison with a PharmD and MBA specializing in pharmacogenomics and clinical product development, with a proven ability to bridge the gap between genomic research and practical patient outcomes. Dr. Lee has more than 10 years of professional experience in clinical pharmacy, academia, and research.

Part of the PlexusDx Education Hub: evidence-based guidance on GLP-1 therapies, weight management, and the genetics behind metabolic decisions. Browse all Peptides & GLP-1 education

This is an independent editorial review. PlexusDx has no commercial relationship with Hims or its parent company, and no affiliate links or compensation are involved.

Ozempic has become shorthand for GLP-1 treatment, but it is a specific brand of semaglutide — and that distinction shapes what any telehealth program can actually offer. This review separates the brand from the molecule and explains how a subscription service like Hims handles semaglutide, with balanced editorial framing and no buying recommendation, as of April 2026.

Ozempic, semaglutide, and brand versus molecule

Semaglutide is a GLP-1 receptor agonist. Ozempic is one FDA-approved brand of semaglutide. The class also includes liraglutide and dulaglutide, while tirzepatide is a separate GIP/GLP-1 dual agonist. Because a brand name and a molecule are not the same thing, reading a program's offering means asking which compound and which product, not just which brand appears in the marketing.

Does a telehealth brand provide Ozempic itself?

Hims (Hims & Hers Health) operates as subscription telehealth: a licensed provider evaluates the patient virtually and writes a prescription routed to either a retail pharmacy for FDA-approved brand products or a 503A compounding pharmacy for compounded semaglutide or tirzepatide. Whether a specific branded product such as Ozempic is offered is shown at intake — confirm current details on Hims's official website.

Compounded semaglutide and the 503A pathway

When a program dispenses compounded semaglutide, it does so through a state-licensed 503A pharmacy that prepares the medication under a prescription. This differs from an FDA-approved branded product dispensed at retail; the two are regulated differently. Knowing which pathway applies is more informative than the brand name in the ad.

The intake and follow-up workflow

Telehealth GLP-1 programs generally follow the same path: an intake covering weight, medical history, and medications; a licensed clinician's review and, if eligible, a prescription; fulfillment through retail or compounding pharmacy; and follow-up for titration and side effects. Provider type, pharmacy partner, and subscription tier vary between brands.

What STEP showed about semaglutide

Semaglutide's weight-management evidence comes largely from the STEP program (The New England Journal of Medicine, 2021); tirzepatide comparators include SURMOUNT (NEJM 2022) and SURMOUNT-OSA (NEJM 2024). Trial populations and endpoints differ, and individual outcomes vary. This review offers no dosing figures or injection technique.

The upstream genetics an Ozempic script does not read

A semaglutide prescription does not account for the genetic terrain it acts on. FTO (fat-mass and obesity-associated) sits with GLP1R (the GLP-1 receptor gene semaglutide targets), MC4R (a melanocortin receptor central to satiety), and TCF7L2 (linked to glucose homeostasis and GLP-1 secretion). These pathway-level variants do not predict response to Ozempic or any compound; they describe the biology being prescribed into.

PlexusDx offers semaglutide and tirzepatide through its Weight Management Protocols, available as Semaglutide Injection, Semaglutide Oral, Tirzepatide Injection, and Tirzepatide Oral. Before any GLP-1 pathway protocol, the Precision Peptide Genetic Test analyzes 14 pathways, 49 peptides, 150+ genetic insights — including FTO, GLP1R, MC4R, and TCF7L2 variants that shape baseline appetite and energy-balance biology. That upstream read is the test before you invest approach: informed conversation over guesswork.

Not affiliated: PlexusDx has no affiliation with Hims and no commercial relationship with any company reviewed here.

Related reading on PlexusDx: Ozempic Review, Ozempic Starting Dose, Ozempic vs Zepbound, Rybelsus vs Ozempic.

Compare the PlexusDx approach: the Weight Management Protocols pair semaglutide and tirzepatide with genetic context, or take the Precision Peptide Genetic Test to map your GLP-1 pathway first.

Frequently Asked Questions

Is Ozempic the same as semaglutide?

Ozempic is one FDA-approved brand of the molecule semaglutide, a GLP-1 receptor agonist. The brand and the molecule are related but not identical, and a telehealth program may involve a branded product, compounded semaglutide, or neither. Confirm which on the brand's own site before assuming a specific product is available.

Does Hims provide Ozempic specifically?

Whether any telehealth brand offers a particular branded product is a program-level detail shown at intake and subject to change. Rather than assume Ozempic itself is available, verify the compound and sourcing — branded retail versus 503A-compounded semaglutide — directly on Hims's own website.

How does the Precision Peptide Genetic Test relate to semaglutide?

It does not predict how you will respond to Ozempic or any compound. It reads pathway-level variants in FTO, GLP1R, MC4R, and TCF7L2 that describe your baseline GLP-1 and appetite biology — context that applies regardless of which program prescribes or which product is dispensed.

Where should I confirm pricing?

Only on the brand's own website, which publishes fees that change over time. Telehealth GLP-1 totals run roughly $200 to $700+ per month as of April 2026 depending on compound, tier, and dispensing pathway. Treat any third-party number as unverified until you check the source directly.

This article is part of the PlexusDx Education Hub. Browse all Peptides & GLP-1 education

Disclaimer: This article is educational. PlexusDx is not affiliated with Hims and has no commercial relationship with the companies reviewed. PlexusDx offers semaglutide and tirzepatide through its own Weight Management Protocols; this review compares approaches in the GLP-1 telehealth space. The Precision Peptide Genetic Test analyzes how your genes influence peptide-related biological pathways — it does not predict response to any specific medication. Consult a qualified healthcare provider before beginning any peptide protocol.

Medical and Editorial Standards

Medical review process: This article was reviewed for medical accuracy, scientific clarity, evidence alignment, and appropriate discussion of genetics, medications, supplements, biomarkers, and health-related claims.

Sources and evidence: PlexusDx educational content is developed using peer-reviewed research, clinical literature, reputable medical references, and, where applicable, public health or regulatory guidance. References are included at the end of the article when scientific, medical, or health-related claims are discussed.

Commercial transparency: PlexusDx offers genetic testing, blood biomarker testing, personalized supplement recommendations, and related precision wellness services. Product mentions are intended to help readers understand available options and should not be interpreted as medical advice.

Important disclaimer: PlexusDx educational content is for informational purposes only and should not be used as a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making decisions about medications, supplements, genetic testing, lab testing, or health-related care.